Literature DB >> 7750948

Infrequent detection of Chlamydia trachomatis in a longitudinal study of women with treated cervical infection.

P E Munday1, B J Thomas, C B Gilroy, C Gilchrist, D Taylor-Robinson.   

Abstract

OBJECTIVE: To determine how often Chlamydia trachomatis cervical infections are detected in women following completion of a currently recommended treatment regimen and the reason for recurrence.
METHODS: A longitudinal follow-up study of 43 initially C trachomatis-positive women for periods of up to two years.
RESULTS: C trachomatis was detected in three women, 19, 16 and about four months, respectively after completion of treatment. All specimens from the other 40 women which were taken during visits two to seven, that is periods of three to 700 days after treatment, were chlamydia-negative.
CONCLUSION: Although C trachomatis is usually eradicated from the genital tract by conventional treatment, occasionally it may be found again. It is difficult to determine whether detection after treatment is due to persistence or reinfection and further studies are required.

Entities:  

Mesh:

Year:  1995        PMID: 7750948      PMCID: PMC1195364          DOI: 10.1136/sti.71.1.24

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  12 in total

1.  Is a test of cure necessary following treatment for cervical infection with Chlamydia trachomatis?

Authors:  K W Radcliffe; D Rowen; D E Mercey; G Mumtaz; G L Ridgway; A J Robinson; J S Bingham
Journal:  Genitourin Med       Date:  1990-12

2.  Detection of Chlamydia trachomatis by the polymerase chain reaction in swabs and urine from men with non-gonococcal urethritis.

Authors:  H M Palmer; C B Gilroy; B J Thomas; P E Hay; C Gilchrist; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

Review 3.  Laboratory techniques for the diagnosis of chlamydial infections.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  Genitourin Med       Date:  1991-06

4.  Emergence of rifampin-resistance in Chlamydia trachomatis.

Authors:  H Keshishyan; L Hanna; E Jawetz
Journal:  Nature       Date:  1973-07-20       Impact factor: 49.962

5.  Latency in human infections with TRIC agents.

Authors:  L Hanna; C R Dawson; O Briones; P Thygeson; E Jawetz
Journal:  J Immunol       Date:  1968-07       Impact factor: 5.422

6.  Sensitivity of detecting Chlamydia trachomatis elementary bodies in smears by use of a fluorescein labelled monoclonal antibody: comparison with conventional chlamydial isolation.

Authors:  B J Thomas; R T Evans; D A Hawkins; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1984-07       Impact factor: 3.411

7.  Therapy of cervical chlamydial infection.

Authors:  R C Brunham; C C Kuo; C E Stevens; K K Holmes
Journal:  Ann Intern Med       Date:  1982-08       Impact factor: 25.391

8.  Improved PCR sensitivity for direct genotyping of Chlamydia trachomatis serovars by using a nested PCR.

Authors:  J Lan; J M Ossewaarde; J M Walboomers; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

9.  Efficacy of treatment regimens for lower urogenital Chlamydia trachomatis infection in women.

Authors:  W R Bowie; L M Manzon; C J Borrie-Hume; A Fawcett; H D Jones
Journal:  Am J Obstet Gynecol       Date:  1982-01-15       Impact factor: 8.661

10.  Cultivation of Chlamydia trachomatis in cycloheximide-treated mccoy cells.

Authors:  K T Ripa; P A Mårdh
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

View more
  2 in total

Review 1.  Concurrent gonococcal and chlamydial infection: how best to treat.

Authors:  A J Robinson; G L Ridgway
Journal:  Drugs       Date:  2000-04       Impact factor: 9.546

2.  Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.

Authors:  U Dreses-Werringloer; I Padubrin; H Zeidler; L Köhler
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.